Maimon Yossi

All filings by Maimon Yossi on record concern Protalix BioTherapeutics, Inc. Over a trading history stretching from 22 February 2008 to 25 February 2008, the count stands at 3 filings.

No open-market purchase appears, only 1 sale worth €71k. Outside the open market, there are 1 share grant and 1 option exercise.

Most recently, on 26 February 2008, the filings show an option exercise worth €56k in Protalix BioTherapeutics, Inc. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.